Marksans Pharma Ltd - MARKSANS PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE750C01026

₹ 104.70 (0.58%)

22 Sep, 2023, 3:57:17 PM

Trade

Marksans Pharma Ltd Stock View

Target | 23 Jan, 2023 80 (-23.59%)

Marksans Pharma Limited is an India-based pharmaceutical company. The Company is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations... Read More

Marksans Pharma Ltd Corporate Actions

02 Aug , 2023

12:00 AM

AGM

Announcement date: 02 Aug , 2023

View Details

02 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Aug , 2023

12:00 AM

Results

View Details

30 May , 2023

12:00 AM

Dividend

Dividend amount: 0.5
Announcement date: 30 May , 2023

View Details

17 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Feb , 2023

12:00 AM

Results

View Details

11 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Nov , 2022

12:00 AM

Results

View Details

Marksans Pharma Ltd News and Update

Indian Stocks End Lower After Rebounding from Three-Day Decline

22 September, 2023 |
8:26 PM

By the day's end, PSU banks and automobiles managed to sustain early gains while information technology, metals and pharma remained under pressure.

Nirma will launch an open offer to purchase a 75% interest in Glenmark Life...

IIFL News Service |
22 September, 2023 |
8:26 PM

Adani Group forms JV for redevelopment of Mumbai’s Dharavi slum

IIFL News Service |
22 September, 2023 |
8:26 PM

Glenmark Pharma to pare 75% stake in Glenmark Lifesciences for Rs 5,651 cro...

IIFL News Service |
22 September, 2023 |
8:26 PM

Marksans Pharma Ltd FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Marksans Pharma Ltd PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceuticals Industries Ltd	1,131.00	65.52	2,71,508.75	380.64	1.02	4,383.34	98.98
Divis Laboratories Ltd	3,708.40	67.32	98,393.27	345.00	0.81	1,730.00	478.60
Cipla Ltd	1,184.35	34.97	95,796.29	895.02	0.72	3,857.73	305.19
Dr Reddys Laboratories Ltd	5,535.00	24.52	92,004.31	1,639.40	0.72	5,420.10	1,235.20
Torrent Pharmaceuticals Ltd	1,853.55	59.77	62,653.02	323.00	1.19	2,078.00	190.75

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Marksans Pharma Ltd

Mark Saldanha
Chairman & Managing Director

Harshavardhan Panigrahi
Company Sec. & Compli. Officer

Seetharama Raju Buddharaju
Non-Exec. & Independent Dir.

Sandra Saldanha
Whole-time Director

Digant Mahesh Parikh
Non-Exec. & Independent Dir.

Varddhman Vikramaditya Jain
Whole-time Director

Abhinna Sundar Mohanty
Non-Exec. & Independent Dir.

Sunny Sharma
Director

Shailaja Vardhan
Independent Director

Summary

Summary Info Not Found

Reports by Marksans Pharma Ltd
Annual ReportAuditors Report
Management DiscussionDirectors Report

Reports by Marksans Pharma Ltd
Investor PresentationConference Call TranscriptConference Call Audio

CALLS						PUTS
Total OI	Chg in Ol	Chg % Ol	LTP	Chg %	Strike Price	Chg %	LTP	Chg % OI	Chg in Ol	Total OI

Marksans Pharma Ltd - MARKSANS PHARMA Share Price

Expiry Date:

Marksans Pharma Ltd Stock View

Marksans Pharma Ltd KEY RATIOS

Marksans Pharma Ltd Corporate Actions

Marksans Pharma Ltd News and Update

Indian Stocks End Lower After Rebounding from Three-Day Decline

Knowledge Center

Marksans Pharma Ltd SHAREHOLDING SNAPSHOT
25 September , 2023 | 04:58 AM

Marksans Pharma Ltd FINANCIALS

Select Period:

Marksans Pharma Ltd QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

QuickLinks for Marksans Pharma Ltd.

Marksans Pharma Information

Marksans Pharma Financials

Marksans Pharma Results

Marksans Pharma News

Marksans Pharma Ltd PEER COMPARISON

MORE ABOUT Marksans Pharma Ltd

Summary

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

Marksans Pharma Ltd - MARKSANS PHARMA Share Price

Expiry Date:

Marksans Pharma Ltd Stock View

Marksans Pharma Ltd KEY RATIOS

Marksans Pharma Ltd Corporate Actions

Marksans Pharma Ltd News and Update

Indian Stocks End Lower After Rebounding from Three-Day Decline

Knowledge Center

Marksans Pharma Ltd SHAREHOLDING SNAPSHOT 25 September , 2023 | 04:58 AM

Marksans Pharma Ltd FINANCIALS

Select Period:

Marksans Pharma Ltd QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

QuickLinks for Marksans Pharma Ltd.

Marksans Pharma Information

Marksans Pharma Financials

Marksans Pharma Results

Marksans Pharma News

Marksans Pharma Ltd PEER COMPARISON

MORE ABOUT Marksans Pharma Ltd

Summary

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

Marksans Pharma Ltd SHAREHOLDING SNAPSHOT
25 September , 2023 | 04:58 AM